503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
24.02%
Some net income increase while BB is negative at -1451.22%. John Neff would see a short-term edge over the struggling competitor.
-24.51%
Both reduce yoy D&A, with BB at -3.85%. Martin Whitman would suspect a lull in expansions or intangible additions for both.
92.25%
Lower deferred tax growth vs. BB's 59500.00%, implying fewer future tax liabilities. David Dodd would confirm there’s no short-term tax shock instead.
7.93%
SBC growth while BB is negative at -23.53%. John Neff would see competitor possibly controlling share issuance more tightly.
-47.87%
Both reduce yoy usage, with BB at -390.00%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
194.53%
AR growth of 194.53% while BB is zero at 0.00%. Bruce Berkowitz would see a mild difference in credit approach that could matter for cash flow.
-221.91%
Negative yoy inventory while BB is 0.00%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
-89.59%
Negative yoy AP while BB is 275.00%. Joel Greenblatt would see quicker payments or less reliance on trade credit than competitor, unless expansions are hindered.
-172.94%
Both reduce yoy usage, with BB at -113.33%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
-62.03%
Both negative yoy, with BB at -117.65%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
3.55%
Some CFO growth while BB is negative at -191.18%. John Neff would note a short-term liquidity lead over the competitor.
-3.44%
Negative yoy CapEx while BB is 18.18%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
70.85%
Acquisition growth of 70.85% while BB is zero at 0.00%. Bruce Berkowitz sees a mild outflow that must deliver synergy to justify the difference.
22.77%
Purchases well above BB's 14.53%. Michael Burry would see major cash outflow into securities vs. competitor’s approach, risking near-term FCF.
-24.36%
We reduce yoy sales while BB is 31.07%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
-67.85%
We reduce yoy other investing while BB is 0.00%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
-20.37%
We reduce yoy invests while BB stands at 75.00%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
No Data
No Data available this quarter, please select a different quarter.
60.29%
Lower share issuance yoy vs. BB's 300.00%, implying less dilution. David Dodd would confirm the firm still has enough capital for expansions.
-16.44%
We cut yoy buybacks while BB is 0.00%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.